Clinical Trials Logo
  1. Home
  2. Thyroid Dysfunction
  3. NCT05786846
  4. Details
NCT05786846 Clinical Trial

Serum Thyroid Function After Iodinated Contrast Administration

Thyroid Dysfunction Clinical Trial

Official title:
Serum Thyroid Function After Iodinated Contrast Administration in Chinese Euthyroid Adults: a Prospective Observational Study.

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05786846
Other study ID # SYSEC-KY-KS-2022-002
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 15, 2023
Est. completion date December 1, 2023

Study information
Verified date February 2023
Source Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Contact Li Yan
Phone 13719165213
Email yanli@mail.sysu.edu.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study investigated the changes in serum thyroid function and urinary iodine levels before and after the use of iodinated contrast to analyze the prevalence of thyroid dysfunction in the Chinese euthyroid adults after using iodinated contrast.

Description:

This study aims to monitor the thyroid function, urinary iodine level, and other indicators of patients after using iodine contrast agents, in order to analyze the prevalence of thyroid dysfunction after using iodine containing contrast agents, and investigate the impact of different iodine contrast agents on thyroid function, in order to provide evidence for the use of iodine contrast agents in clinical practice and the risk prevention of subsequent thyroid diseases.

Recruitment information / eligibility
Status Recruiting
Enrollment 400
Est. completion date December 1, 2023
Est. primary completion date July 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - patients who use iodinated contrast agent Exclusion Criteria: - patients with the following diseases: malignant tumor, critical illness (admitted to ICU), mental disease, hypothalamus-pituitary disease. - administration of anti-thyroid drugs (methimazole, propylthiouracil), levothyroxine, compound iodine solution, amiodarone, immunostaining point inhibitor, tyrosine kinase inhibitor, interferon, interleukin-6, lithium, glucocorticoids ß Receptor blockers, dopamine, dobutamine, bromocriptine, octreotide, phenobarbital, phenytoin sodium, rifampicin, and carbamazepine within the past 6 months

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Iodinated contrast agents
Patients who use iodinated contrast agents clinically

Locations
Country Name City State
China Sun Yat-Sen Memorial Hospital Guangzhou

Sponsors (1)
Lead Sponsor Collaborator
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary Incidence rate of thyroid dysfunction after administration of iodine contrast agent. up to 32 weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT01682785 - Incidence of Metabolic Syndrome and Thyroid Dysfunction in Patients With Major Depressive Disorder N/A
Completed NCT04470440 - Thyroid Dysfunction and Nivolumab Reponse in NSCLC
Not yet recruiting NCT04809454 - Frequency of Florid Hyperthyroidism In Patients Taking Iodinated Salt
Recruiting NCT05980923 - Thyroid Profiles in Patients With Acute Illness
Recruiting NCT03754621 - Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey
Not yet recruiting NCT04323007 - Thyroid Dysfunction in Patients With Nephrotic Syndrome N/A
Completed NCT04013308 - Iontophoresis With Potassium Iodide and Thyroid Function N/A
Completed NCT05385029 - Fetal and Neonatal Thyroid in Pregnancies With Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS- COV2 ) COVID-19
Not yet recruiting NCT06293534 - Thyroid Dysfunction in Patients With Major Psychiatric Disorders
Terminated NCT03787303 - Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma Phase 2
Completed NCT02832960 - The TRUST Trial - CardioVascular Imaging ECHO Phase 4
Completed NCT02832934 - The TRUST Study - CardioVascular Imaging IMT Phase 4
Completed NCT00592514 - Thyroid Dysfunction in Head and Neck Surgery Patients N/A
Terminated NCT00504218 - Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients
Active, not recruiting NCT04658524 - Evaluation of Thyroid Function in Patients With Chronic Kidney Disease
Completed NCT02500342 - Effect of Thyroid Hormone Replacement on Fatigability in Untreated Older Adults With Subclinical Hypothyroidism Phase 4
Completed NCT02491008 - Novel Biomarkers and Skeletal Outcomes Associated With Subclinical Thyroid Dysfunction Phase 4
Not yet recruiting NCT06185309 - Evaluation of Different Psychiatric Symptoms in Patients With Thyroid Dysfunction
Not yet recruiting NCT04613323 - Management of Thyroid Function in Hashimoto's Thyroiditis During Pregnancy
Recruiting NCT04019509 - The Influence of Different Thyroid Autoantibodies on Thyroid Function and Pregnancy Outcome After Assisted Reproductive Technology N/A